Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration
about
Virological outcomes and drug resistance in Chinese patients after 12 months of 3TC-based first-line antiretroviral treatment, 2011-2012CD4 trajectory adjusting for dropout among HIV-positive patients receiving combination antiretroviral therapy in an East African HIV care centre.Retention and risk factors for attrition in a large public health ART program in Myanmar: a retrospective cohort analysis.Incidence of serious morbidity in HIV-infected adults on antiretroviral therapy in a West African care centre, 2003-2008Morbidity and mortality according to latest CD4+ cell count among HIV positive individuals in South Africa who enrolled in project PhidisaSevere morbidity after antiretroviral (ART) initiation: active surveillance in HIV care programs, the IeDEA West Africa collaborationCauses of Death among AIDS Patients after Introduction of Free Combination Antiretroviral Therapy (cART) in Three Chinese Provinces, 2010-2011.Rates and risk factors associated with the progression of HIV to AIDS among HIV patients from Zhejiang, China between 2008 and 2012Efficacy and HIV drug resistance profile of second-line ART among patients having received long-term first-line regimens in rural China.Loss to Follow-up Trends in HIV-Positive Patients Receiving Antiretroviral Treatment in Asia From 2003 to 2013.High prevalence of being Overweight and Obese HIV-infected persons, before and after 24 months on early ART in the ANRS 12136 Temprano TrialWhen to start ART in Africa--primarily guided by RCTs or patient autonomy?Outcomes and factors associated with survival of patients with HIV/AIDS initiating antiretroviral treatment in Liangshan Prefecture, southwest of China: A retrospective cohort study from 2005 to 2013HPTN 071 (PopART): a cluster-randomized trial of the population impact of an HIV combination prevention intervention including universal testing and treatment: mathematical modelDisease patterns and causes of death of hospitalized HIV-positive adults in West Africa: a multicountry survey in the antiretroviral treatment era.The HIV epidemic in Southern Africa - Is an AIDS-free generation possible?The REVAMP trial to evaluate HIV resistance testing in sub-Saharan Africa: a case study in clinical trial design in resource limited settings to optimize effectiveness and cost effectiveness estimates.Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study.Patients who present late to HIV care and associated risk factors in Nigeria.Predictors of HIV virological failure and drug resistance in Chinese patients after 48 months of antiretroviral treatment, 2008-2012: a prospective cohort study.Impact of Unplanned Care Interruption on CD4 Response Early After ART Initiation in a Nigerian Cohort.Clinical trials provide the evidence critical for patient empowerment.Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality.From CD4-Based Initiation to Treating All HIV-Infected Adults Immediately: An Evidence-Based Meta-analysis.The Continuing Burden of Advanced HIV Disease Over 10 Years of Increasing Antiretroviral Therapy Coverage in South Africa.
P2860
Q28539652-C9E6E1E5-C934-4862-A81D-ADEC53354F5AQ34059861-0D358ED2-4E6F-4452-B57D-ECF955BCBCEFQ34277977-CD569C95-FA69-4DB4-BDAA-50DA83D9766EQ35076875-DC98EB74-9E2B-45C0-90F9-38C0636B3293Q35345807-C8C556E0-DD65-4035-A6B7-B1B2D44F7B28Q35409929-50510DD2-6D85-431E-9195-8C0A0293AC1EQ35823291-0FC50A58-E827-4AF9-85A0-B4BE5C9FAFF9Q36092212-17BF93DC-B4DD-4381-9EF8-BF5EE3CB41F4Q36134243-65BAEAC3-09C6-49A0-A72D-4B76D51B5B4AQ36262350-17B719A4-D013-4929-9B24-C1D1E33A0D2BQ36621913-EADECFC3-8279-4F32-BD1D-32034785E7DDQ37180010-2C4D5144-2D3F-4240-89E0-CF18DDDC178AQ37327900-0FD34E1B-AAE2-4A33-A3E1-5F436D9BB2A0Q37483779-3951D938-16EE-4C07-B591-F2A6D920710CQ37693285-76D2E118-1269-47D3-97C2-CF64C7088038Q38199989-C7FCC567-D813-4502-AFAC-A1C14449FEACQ38673571-61CE1820-29F6-4606-9DB9-ADF8FB44974EQ38684466-BAB2BC58-F703-4D2D-84D9-E8D50A7964A2Q39211016-E0F3A8E5-AF21-4470-9128-ECDE0E58737DQ40052482-DED172CA-8B06-4713-AB02-AD1CE45CF82FQ40373312-2ACAE2D3-3FD6-4097-81B1-D47DD1B4696BQ42561689-21EAB475-219A-4B25-858F-28D33F814E64Q46789177-1C5A9099-2DA0-4DEE-BD9E-11EF6AEDA5E0Q50321109-72F175BB-24DD-4531-A812-B2D02A538C8CQ51411857-616364DA-5565-4C4D-B4DD-30E28F472A54
P2860
Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Mortality, AIDS-morbidity, and ...... m the ANRS 12222 collaboration
@ast
Mortality, AIDS-morbidity, and ...... m the ANRS 12222 collaboration
@en
type
label
Mortality, AIDS-morbidity, and ...... m the ANRS 12222 collaboration
@ast
Mortality, AIDS-morbidity, and ...... m the ANRS 12222 collaboration
@en
prefLabel
Mortality, AIDS-morbidity, and ...... m the ANRS 12222 collaboration
@ast
Mortality, AIDS-morbidity, and ...... m the ANRS 12222 collaboration
@en
P2093
P2860
P50
P921
P1476
Mortality, AIDS-morbidity, and ...... m the ANRS 12222 collaboration
@en
P2093
ANRS 12222 Morbidity Mortality Study Group
Albert Minga
Besigin Tonwe-Gold
Charlotte Lewden
Christian Laurent
Djimon Marcel Zannou
Eitel Mpoudi-Ngole
Ibra Ndoye
Isabelle Fournier-Nicolle
Issouf Konate
P2860
P304
P356
10.1097/QAI.0B013E3182821821
P407
P577
2013-04-01T00:00:00Z